Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo.

Cecil DL, Slota M, O'Meara MM, Curtis BC, Gad E, Dang Y, Herendeen D, Rastetter L, Disis ML.

Clin Cancer Res. 2017 Jul 1;23(13):3396-3404. doi: 10.1158/1078-0432.CCR-16-1678. Epub 2016 Dec 30.

2.

Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer.

Watt WC, Cecil DL, Disis ML.

Semin Immunopathol. 2017 Apr;39(3):245-253. doi: 10.1007/s00281-016-0596-7. Epub 2016 Dec 14. Review.

PMID:
27975138
3.

Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer.

Liao JB, Ovenell KJ, Curtis EE, Cecil DL, Koehnlein MR, Rastetter LR, Gad EA, Disis ML.

J Immunother Cancer. 2015 May 19;3:16. doi: 10.1186/s40425-015-0060-6. eCollection 2015.

4.

Th1 epitope selection for clinically effective cancer vaccines.

Disis ML, Watt WC, Cecil DL.

Oncoimmunology. 2014 Dec 13;3(9):e954971. eCollection 2014 Oct.

5.

Elimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity.

Cecil DL, Holt GE, Park KH, Gad E, Rastetter L, Childs J, Higgins D, Disis ML.

Cancer Res. 2014 May 15;74(10):2710-8. doi: 10.1158/0008-5472.CAN-13-3286. Epub 2014 Apr 28.

6.

A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast disease.

Disis ML, Gad E, Herendeen DR, Lai VP, Park KH, Cecil DL, O'Meara MM, Treuting PM, Lubet RA.

Cancer Prev Res (Phila). 2013 Dec;6(12):1273-82. doi: 10.1158/1940-6207.CAPR-13-0182. Epub 2013 Oct 23.

7.

T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity.

Cecil DL, Park KH, Gad E, Childs JS, Higgins DM, Plymate SR, Disis ML.

Breast Cancer Res Treat. 2013 Jun;139(3):657-65. doi: 10.1007/s10549-013-2577-z. Epub 2013 Jun 8.

PMID:
23749321
8.

Arterial calcification is driven by RAGE in Enpp1-/- mice.

Cecil DL, Terkeltaub RA.

J Vasc Res. 2011;48(3):227-35. doi: 10.1159/000318805. Epub 2010 Nov 23.

9.

The pattern recognition receptor CD36 is a chondrocyte hypertrophy marker associated with suppression of catabolic responses and promotion of repair responses to inflammatory stimuli.

Cecil DL, Appleton CT, Polewski MD, Mort JS, Schmidt AM, Bendele A, Beier F, Terkeltaub R.

J Immunol. 2009 Apr 15;182(8):5024-31. doi: 10.4049/jimmunol.0803603.

10.
11.

Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products.

Cecil DL, Johnson K, Rediske J, Lotz M, Schmidt AM, Terkeltaub R.

J Immunol. 2005 Dec 15;175(12):8296-302.

12.

Role of interleukin-8 in PiT-1 expression and CXCR1-mediated inorganic phosphate uptake in chondrocytes.

Cecil DL, Rose DM, Terkeltaub R, Liu-Bryan R.

Arthritis Rheum. 2005 Jan;52(1):144-54. Erratum in: Arthritis Rheum. 2006 Jul;54(7):2320.

Supplemental Content

Loading ...
Support Center